News Roundup: New ADHD Prodrug Review, Study Finds Second COVID-19 Vaccine Dose Safe
Here’s a roundup of the latest news coverage from Drug Topics®.
New Prodrug for ADHD in School-aged Children
Ser/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.
It’s Safe to Receive Your Second COVID-19 Vaccine After an Allergic Reaction, Study Finds
A study published in JAMA Internal Medicine explained that a first dose reaction to COVID-19 vaccination should not deter people from receiving their second dose.
What’s The Risk of Pertussis in Kids Who Are Undervaccinated or Delayed in Vaccination?
For children who have either experienced a delay in pertussis vaccination or who haven’t received the recommended number of doses, what is their risk of pertussis? A new study provides answers.
Study Links Processed Food to Inflammatory Bowel Disease
A study published in The BMJ revealed a link between ultra-processed foods and a higher risk of IBD.
Flu Season is Approaching, but Experts Don't Know What to Expect
Although COVID-19 safety measures helped squash the number of influenza cases last season, pharmacists are revving up vaccination programs and testing.
OTC and Prescription Products Can Relieve Psoriasis
Pharmacists can educate patients on psoriasis treatments and lifestyle modifications, address expected drug-related adverse effects (AEs), and improve medication adherence.
How to Tactfully Handle Naloxone Counseling
Naloxone education often requires difficult but necessary conversations with patients.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
